Profile
Catherine Hu worked as a Director of Investor Relations at Alexion Pharmaceuticals, Inc. She then worked as an Executive Director of Investor Relations and Corporate Communications at Scholar Rock Holding Corp.
from 2018 to 2021.
Ms. Hu received an undergraduate degree from The Leonard N Stern School of Business.
Former positions of Catherine Hu
| Companies | Position | End |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Investor Relations Contact | 2021-09-30 |
| ALEXION PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Training of Catherine Hu
| The Leonard N Stern School of Business | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Catherine Hu
